Genzyme Corporation (GENZ) Tops Q4 EPS by 2c, Guides for Q1 and FY
Tweet Send to a Friend
Genzyme Corporation (Nasdaq: GENZ) reports Q4 (non-GAAP) EPS of $0.77, 2 cents better than estimates. Revenues were $854.2 million ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
